WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009123877) A METHOD OF TREATING A NERVOUS SYSTEM DISORDER BY MODULATION OF NEUROGENESIS WITH MCC-257
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/123877    International Application No.:    PCT/US2009/037981
Publication Date: 08.10.2009 International Filing Date: 23.03.2009
IPC:
A61K 31/575 (2006.01), A61P 25/00 (2006.01)
Applicants: BRAINCELLS, INC. [US/US]; 3565 General Atomics Court, Suite 200 San Diego, CA 92121 (US) (For All Designated States Except US).
BARLOW, Carrolee [US/US]; (US) (For US Only).
CARTER, Todd, A. [US/US]; (US) (For US Only).
MORSE, Andrew [US/US]; (US) (For US Only).
TREUNER, Kai [DE/US]; (US) (For US Only).
LORRAIN, Kym, I. [US/US]; (US) (For US Only)
Inventors: BARLOW, Carrolee; (US).
CARTER, Todd, A.; (US).
MORSE, Andrew; (US).
TREUNER, Kai; (US).
LORRAIN, Kym, I.; (US)
Agent: DOW, Karen, B.; Sughrue Mion, PLLC 501 West Broadway Suite 1600 San Diego, CA 92101-3595 (US)
Priority Data:
61/038,570 21.03.2008 US
Title (EN) A METHOD OF TREATING A NERVOUS SYSTEM DISORDER BY MODULATION OF NEUROGENESIS WITH MCC-257
(FR) PROCÉDÉ DE TRAITEMENT D'UN TROUBLE DU SYSTÈME NERVEUX PAR MODULATION DE NEUROGENÈSE AVEC MCC-257
Abstract: front page image
(EN)The disclosure provides methods and a composition for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis by use of (5-acetamido-N-(5alρha-cholestan-3alpha-yl)-3,5-dideoxy-2-O- methyl-D-glycero-alpha-D-galacto-non-2-ulopyranosonamide(MCC-257). The disclosure also includes methods and a composition for stimulating or activating the formation of new nerve cells based on the application of MCC-257.
(FR)L'invention concerne des procédés et une composition pour traiter des maladies et des états du système nerveux central et périphérique en stimulant ou en augmentant la neurogenèse par l’utilisation de (5-acétamido-N-(5-alpha-cholestan-3-alpha-yl)-3,5-didésoxy-2-O-méthyl-D-glycéro-alpha-D-galacto-non-2-ulopyranosonamide (MCC-257). La description comprend également des procédés et une composition pour stimuler ou activer la formation de nouvelles cellules nerveuses sur la base de l'application de MCC-257.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)